Pfizer
PFE
PFE
2,983 hedge funds and large institutions have $100B invested in Pfizer in 2024 Q4 according to their latest regulatory filings, with 377 funds opening new positions, 932 increasing their positions, 1,460 reducing their positions, and 245 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $109B → $100B (-$8.71B)
15% less call options, than puts
Call options by funds: $3.28B | Put options by funds: $3.87B
36% less repeat investments, than reductions
Existing positions increased: 932 | Existing positions reduced: 1,460
Holders
2,983
Holding in Top 10
42
Calls
$3.28B
Puts
$3.87B
Top Buyers
| 1 | +$687M | |
| 2 | +$427M | |
| 3 | +$417M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$185M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$147M |
Top Sellers
| 1 | -$644M | |
| 2 | -$337M | |
| 3 | -$293M | |
| 4 |
JP Morgan Chase
New York
|
-$285M |
| 5 |
Barclays
London,
United Kingdom
|
-$277M |